
Michael Paul Cancro
VerifiedUniversity of Pennsylvania · Rehabilitation Medicine
Active 1976–2025
About
Michael Paul Cancro, Ph.D., is Vice Chair for Faculty Development and Academic Affairs in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania. His research focuses on B lymphocyte development, selection, and homeostasis, as well as the immunobiology of aging. His laboratory has made significant contributions to understanding B cell development, including defining the transitional B cell subset and elucidating how cytokine BLyS (BAFF) and its receptors control peripheral B cell selection and numbers. More recently, his work has centered on the discovery of a novel B cell subset called Age Associated B cells (ABCs), characterized by the expression of the transcriptional regulator Tbet. This subset enlarges continuously with age and includes spleen-resident memory B cells that are crucial for anti-microbial immunity but are also expanded in autoimmune diseases. His ongoing research aims to understand the origins of ABCs and their roles in protective immunity and autoimmune conditions.
Research topics
- Biology
- Immunology
- Genetics
- Internal medicine
- Virology
- Molecular biology
- Biochemistry
- Medicine
Selected publications
T-bet+CD11c+ age-associated B cells resist BLyS- and CD20-targeted ablation in murine lupus models
Journal of Autoimmunity · 2025-04-01 · 3 citations
articleOpen accessSenior authorB cell ablation strategies show promise for treating humoral autoimmune diseases, but their impact on pathogenic tissue-localized T-bet + CD11c + age-associated B cells (ABCs) is poorly defined. We assessed whether mAb-mediated B cell depletion impacts ABCs and other splenic B cell subsets in two mouse models of lupus. Following disease onset, we injected NZBxNZWF1 mice (NZBWF1; n = 72) or bm12 chronic graft versus host disease mice (cGVHD; n = 59) with 0.2 mg or 1 mg of anti-BLyS (10F4), anti-CD20 (18B12), combined treatment, or saline. Spleens were harvested after two weeks and B cell subset representation was analyzed via flow cytometry. In the NZBWF1 model, lymphopenia and resistance to 10F4 and 18B12 that arose concomitant with disease onset complicated interpretation, as ablative activity was partial and variable in the follicular (FO) and marginal zone (MZ) pools. Conversely, the T-bet + CD11c + ABC pool was unchanged or enlarged versus controls and was entirely refractory to antibody treatments. In the cGVHD model, both 10F4 and 18B12 treatments ablated nearly all FO B cells. MZ B cells were profoundly ablated by 10F4 but spared by 18B12 treatment, whereas 10F4 treatment spared a small, undefined subset of splenic B cells that was ablated by 18B12. In contrast, T-bet + CD11c + ABCs were minimally impacted by either reagent alone or combined, regardless of dose. The spleen-resident T-bet + CD11c + ABC pool resists anti-BLyS and anti-CD20 ablative treatment. These findings have implications for antibody-mediated ablative strategies in patients with autoimmune diseases. • Anti-CD20 or anti-BLyS spare some splenic B cell subsets in mouse lupus models. • Combined anti-CD20/anti-BLyS yields complimentary subset ablation. • Neither anti-CD20 nor anti-BLyS deplete splenic age-associated B cells.
B cells and aging: a historical perspective
The Journal of Immunology · 2025-03-19 · 1 citations
article1st authorCorrespondingNormal Treg homeostasis and suppressive function require both FOXP1 and FOXP4
JCI Insight · 2025-08-12 · 4 citations
articleOpen accessFOXP3+ Treg cells are critical for immune tolerance. Genetic deletion of the Forkhead domain-containing proteins of the FOXP-subfamily member FOXP1 from Tregs results in impaired function associated with reduced CD25 expression and IL-2 signaling, but to date the only other FOXP family member expressed in Tregs, FOXP4, has been minimally studied. To investigate the potential functional interactions among FOXP family members in Tregs, we specifically deleted Foxp1, Foxp4, or both in FOXP3+ committed Tregs in mice. Our findings show that mice with combined, but not individual, deficiency in FOXP1 and FOXP4 exhibit lymphoproliferation, inflammation, autoimmunity, and early lethality. The combined absence of FOXP1 and FOXP4 in Tregs results in an activated/effector-like phenotype with compromised suppressive function in peripheral lymphoid organs, an enhanced germinal center response, and proinflammatory cytokine production. We further show that FOXP1 and FOXP4 bind to Il2ra promoter regions to regulate CD25 expression in Tregs. Through pairwise comparison among mouse strains with Treg-specific deletion of Foxp1, Foxp4, or both, our findings indicate a nonredundant but insufficient role of FOXP4 in Treg function.
T-bet–expressing B cells promote atherosclerosis in apolipoprotein E–deficient mice
The Journal of Immunology · 2025-02-26 · 4 citations
articleOpen accessSenior authorThe humoral immune system influences the development of atherosclerosis, but the contributions of specific memory B cell subsets and IgG isotypes are poorly understood. We assessed the relationship between atherosclerosis and age-associated B cells (ABCs), a T-bet-expressing memory B cell subset that is enriched for IgG2c production and implicated in humoral autoimmunity. We found increased numbers of splenic CD11c+ ABCs in 6-mo-old, chow-fed Apoe-/- mice versus C57BL/6 control mice, which were exacerbated by high-fat diet. Deletion of T-bet in the B lineage in high-fat diet-fed Apoe-/- mice reduced aortic lesion area, and this correlated with decreased splenic CD11c+ B cells and reduced serum oxidized low-density lipoprotein-specific IgG2c. Our findings suggest that T-bet-expressing B cells are atherogenic agents in the Apoe-/- model and indicate that interventions to inhibit a T-bet-driven humoral response may improve atherosclerotic disease.
132 Expansion of Tbet+ T and B cells in the lung of hypomorphic Rag1 mice
Clinical Immunology · 2024-04-23
article<i>Xist</i> Deletion in B Cells Results in Systemic Lupus Erythematosus Phenotypes
bioRxiv (Cold Spring Harbor Laboratory) · 2024-05-18 · 14 citations
preprintOpen accessSUMMARY Systemic lupus erythematosus (SLE) is an autoimmune disease preferentially observed in females. X-linked gene expression in XX females is normalized to that of XY males by X-Chromosome Inactivation (XCI). However, B cells from female SLE patients and mouse models of SLE exhibit mislocalization of Xist RNA, a critical regulator of XCI, and aberrant expression of X-linked genes, suggesting that impairment of XCI may contribute to disease. Here, we find that a subset of female mice harboring a conditional deletion of Xis t in B cells (“Xist cKO”) spontaneously develop SLE phenotypes, including expanded activated B cell subsets, disease-specific autoantibodies, and glomerulonephritis. Moreover, pristane-induced SLE-like disease is more severe in Xist cKO mice. Activated B cells from Xist cKO mice with SLE phenotypes have increased expression of proinflammatory X-linked genes implicated in SLE. Together, this work indicates that impaired XCI maintenance in B cells directly contributes to the female-bias of SLE.
Directing risky traffic in B cells with TNIP1
Nature Immunology · 2024-07-26
article1st authorCorresponding<scp>ABCs</scp> begin with <scp>ZEB2</scp>
Immunology and Cell Biology · 2024-03-25 · 4 citations
letterOpen accessSenior authorCorrespondingAge-associated B cells (ABCs) are a stable subset of memory B lymphocytes that develop during microbial infections and in autoimmune diseases. Despite growing appreciation of their phenotypic and functional characteristics, the transcriptional networks involved in ABC fate commitment and maintenance have remained elusive. In their recent publication, Dai et al. tackle this problem, leveraging both mouse models and human diseases to reveal zinc finger E-box-binding homeobox 2 (ZEB2) as a key transcriptional regulator of ABC lineage specification. In aggregate, their results show that ZEB2, a member of the zinc finger E homeobox binding family, promotes ABC differentiation by repressing alternative differentiative fates and targeting genes important for ABC character and function. Moreover, their results strengthen the case for causal links between ABC fate and function in autoimmune pathologies.
171 Assessment and Characterization of Tbet+ B Cells in Various Inborn Errors of Immunity (IEIs)
Clinical Immunology · 2024-04-23
articleClinical Immunology · 2023-05-01
article
Recent grants
NIH · $2.1M · 2012
NIH · $1.0M · 2002
NIH · $1.9M · 2009
NIH · $1.1M · 2005
Immune System Development and Regulation
NIH · $4.2M · 2003–2026
Frequent coauthors
- 39 shared
Jean L. Scholz
University of Pennsylvania
- 28 shared
Mark J. Shlomchik
University of Pittsburgh
- 25 shared
Lynn G. Hannum
Colby College
- 25 shared
Matthew H. Levine
University of Pennsylvania
- 25 shared
Charles A. Janeway
St. John’s Health Sciences Centre
- 25 shared
Derek B. Sant’Angelo
Johnson University
- 25 shared
Ann M. Haberman
Yale University
- 24 shared
Norman R. Klinman
Education
- 1984
Master of Letters, Honorary
University of Pennsylvania
- 1978
Post doctoral, Pathology/Immunology
University of Pennsylvania
- 1976
Ph.D. (Genetics, Cancer Biology), Zoology
University of Maryland
- 1972
Bachelor of Science, Zoology
University of Maryland
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Michael Paul Cancro
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup